Red Sox face dilemma as Devers adamantly opposes position change amid Bregman signing
FDA ends shortage of Ozempic and Wegovy, but compounding pharmacies must stop producing unapproved versions, potentially impacting patients who relied on more affordable options.
Red Sox face dilemma as Devers adamantly opposes position change amid Bregman signing
FDA ends shortage of Ozempic and Wegovy, but compounding pharmacies must stop producing unapproved versions, potentially impacting patients who relied on more affordable options.